Biopharmaceutical
Ascendis Pharma is a global biopharmaceutical company committed to developing innovative therapies that address unmet medical needs. The company applies its proprietary TransCon® technology platform to advance programs in its Endocrinology Rare Disease portfolio, with potential applications across multiple therapeutic areas. Guided by core values of Patients, Science, and Passion, Ascendis operates research facilities and offices across Europe and the United States, collaborating with partners worldwide to bring best-in-class therapies to patients globally. The company is focused on successfully launching and ensuring accessibility of its endocrinology portfolio across international markets including Europe, the Americas, Asia, the Middle East, and Africa.
Beta · Sourced from candidate reports
Be the first to share your experience with Ascendis Pharma.
Your reply helps other candidates know what to expect.
